RAFFA WEALTH MANAGEMENT, LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$482	Buy	2 +1	+100%	+$219	﹤0.01%	1189
2026 Q1	$189	Buy	+1	New	+$175	﹤0.01%	1188
2016 Q4	–	Sell	-10	Closed	-$1.22K	–	889
2016 Q3	$1.22K	Hold	10	–	–	﹤0.01%	364
2016 Q2	$1.41K	Buy	10 +1	+11%	+$147	﹤0.01%	316
2016 Q1	$1.18K	Hold	9	–	–	﹤0.01%	358
2015 Q4	$1.26K	Hold	9	–	–	﹤0.01%	340
2015 Q3	$1.2K	Hold	9	–	–	﹤0.01%	347
2015 Q2	$1.58K	Hold	9	–	–	﹤0.01%	305
2015 Q1	$1.55K	Buy	+9	New	+$1.54K	﹤0.01%	297

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's JAZZ Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Jazz Pharmaceuticals (JAZZ) stake by 100% in Q2 2026, buying an estimated $219 and bringing the position to 2 shares worth $482. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in JAZZ in Q1 2015 and has held it in 9 quarters since. The position peaked at $1.58K in Q2 2015. 164 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 2 shares of Jazz Pharmaceuticals worth $482 as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
Jazz Pharmaceuticals made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1189 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Jazz Pharmaceuticals in Q1 2015 and has held it in 9 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's Jazz Pharmaceuticals position peaked at $1.58K in Q2 2015.
164 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.